BGM Group Ltd. (NAS: BGM) Stock Analysis & Fundamentals

BGMBGM Group Ltd.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · bgmgroupltd.com

0.2643USD+0.38%Mkt Cap: 105.48M $P/E: —Today

BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segme…

Industry Peers

Drug Manufacturers - Specialty & Generic

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB (publ)

$15.34BUSDP/E 117.3

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

Amylyx Pharmaceuticals Inc. Common Stock

$4.30BUSD

HIK

Hikma Pharmaceuticals PLC

$3.69BUSDP/E 12.7

ROVI

Laboratorios Farmaceuticos Rovi, S.A.

$3.32BUSDP/E 16.5

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap105.48M $

Enterprise Value48.36M $

Revenue (TTM)37.92M $

Gross Profit6.31M $

Net Income (TTM)-19.94M $

Revenue/Share0.3350 USD

Last Price0.2643 USD

Fiscal Year EndSep 2025

MR QuarterSep 2025

Employees—

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-4.35

EV/Revenue1.28

P/S2.78

P/B0.14

EPS (TTM)-0.17

EPS (Forward)—

52W Range

0.252346% of range0.2783

52W High0.2783 USD

52W Low0.2523 USD

Profitability

Gross Margin16.64%

Oper. Margin-43.81%

EBITDA Margin-29.32%

Profit Margin-52.59%

ROE-5.10%

ROA-4.60%

Growth

Revenue Growth88.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.37M $

CapEx (TTM)2.19M $

FCF Margin9.23%

FCF Yield3.32%

Net Debt-8.88M $

Net Debt/EBITDA0.80

Balance Sheet

Debt/Equity0.00

Current Ratio1.24

Quick Ratio0.65

Book Value/Sh1.948 USD

Cash/Share0.0540 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateFeb 27, 2023

Pay DateMar 6, 2023

Splits

Last Split1:5

Split DateJun 21, 2024

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.380.62M

Float133.30M

Insiders38.05%

Institutions0.10%

Short Interest

Short Ratio0.6d

Short % Float0.07%

Short % Out.0.05%

Shares Short209.18K

Short (prev mo.)178.28K

Technical

SMA 500.3220 (-17.9%)

SMA 2002.233 (-88.2%)

Beta—

S&P 52W Chg21.00%

Avg Vol (30d)33.75K

Avg Vol (10d)480.89K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—